A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study (Q35126038)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Benjamin Hibbert

1

object named as

Benjamin Hibbert

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael Froeschl

11

object named as

Michael Froeschl

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

object named as

Marino Labinaz

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

object named as

Alexander Dick

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jean-François Marquis

12

object named as

Jean-François Marquis

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

4

object named as

Trevor Simard

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ali Pourdjabbar

3

object named as

Ali Pourdjabbar

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michel R. Le May

14

object named as

Michel R Le May

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christopher Glover

10

object named as

Christopher Glover

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

object named as

Ronnen Maze

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Melissa Blondeau

7

object named as

Melissa Blondeau

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

F Daniel Ramirez

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rohit Moudgil

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Derek Y F So

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

20 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

e92078

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution 4.0 International

20 March 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Response variability to P2Y12 receptor inhibitors: expectations and reality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

A citywide protocol for primary PCI in ST-segment elevation myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961303

13 July 2018

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: combined analysis of the ONSET/OFFSET and RESPOND studies

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092078

21 January 2018

Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bedside monitoring to adjust antiplatelet therapy for coronary stenting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651043

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0092078

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2014PLoSO...992078H

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126038&oldid=2144108047"